Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06505187 · ClinicalTrials.gov registry record · Phase 2
Celecoxib for ENT Pain Management
A Phase 2 study of Parotidectomy, sponsored by University of Wisconsin, Madison.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 84
- Enrollment target
- 1
- Study location
NCT06505187 is a Phase 2 study of Parotidectomy that is actively recruiting participants, run by University of Wisconsin, Madison. The registered enrollment target is 84 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06505187, a Phase 2 study of Parotidectomy, is actively recruiting participants, sponsored by University of Wisconsin, Madison.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 84 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to find out whether pain can be managed after an operation with celecoxib instead of oxycodone. The main question it aims to answer is if use of celecoxib plus Tylenol reduces the need for oxycodone. Researchers will compare the combination of celecoxib and Tylenol to a placebo to find out whether celecoxib works to manage pain. Participants will: * Take celecoxib, or a placebo, plus Tylenol with opioids as needed * Keep a diary of their pain between visits * Complete questionnaires
Conditions Studied
Interventions
- DRUG placebo
- DRUG Celecoxib
- DRUG Tylenol
- DRUG Oxycodone
Study Locations (1)
Wisconsin
- University of Wisconsin - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2025-02-28 |
| Est. Completion | 2026-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06505187
The ClinicalTrials.gov registry entry for NCT06505187 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Parotidectomy appearing as the primary indexed condition, and to 4 interventions - of which placebo is the first listed.
NCT06505187 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.
Frequently Asked Questions
What is clinical trial NCT06505187 about?
NCT06505187 is a clinical study titled "Celecoxib for ENT Pain Management". The goal of this clinical trial is to find out whether pain can be managed after an operation with celecoxib instead of oxycodone. The main question it aims to answer is if use of celecoxib plus Tylenol reduces the need for oxycodone. Researchers will compare the combination of celecoxib and Tyleno...
What is the current status of trial NCT06505187?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 84 participants. The study started on 2025-02-28. Estimated completion is 2026-09.
What conditions does trial NCT06505187 study?
This clinical trial studies the following conditions: Parotidectomy.
What interventions are being tested in trial NCT06505187?
The interventions under investigation include: placebo (DRUG), Celecoxib (DRUG), Tylenol (DRUG), Oxycodone (DRUG).
Who is sponsoring clinical trial NCT06505187?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06505187 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.